AAAAAA

   
Results: 1-8 |
Results: 8
Extent and distribution of in-stent intimal hyperplasia and edge effect ina non-radiation stent population
Authors: Weissman, NJ Wilensky, RL Tanguay, JF Bartorelli, AL Moses, J Williams, DO Bailey, S Martin, JL Canos, MR Rudra, H Popma, JJ Leon, MB Kaplan, AV Mintz, GS
Citation: Nj. Weissman et al., Extent and distribution of in-stent intimal hyperplasia and edge effect ina non-radiation stent population, AM J CARD, 88(3), 2001, pp. 248-252
Combination therapy with clopidogrel and aspirin after coronary stenting
Authors: Kolansky, DM Klugherz, BD Curran, SC Herrmann, HC Magness, K Wilensky, RL Hirshfeld, JW
Citation: Dm. Kolansky et al., Combination therapy with clopidogrel and aspirin after coronary stenting, CATHET C IN, 50(3), 2000, pp. 276-279
Gene delivery from a DNA controlled-release stent in porcine coronary arteries
Authors: Klugherz, BD Jones, PL Cui, XM Chen, WL Meneveau, NF DeFelice, S Connolly, J Wilensky, RL Levy, RJ
Citation: Bd. Klugherz et al., Gene delivery from a DNA controlled-release stent in porcine coronary arteries, NAT BIOTECH, 18(11), 2000, pp. 1181-1184
Vascular remodeling and the local delivery of cytochalasin B after coronary angioplasty in humans
Authors: Lehmann, KG Popma, JJ Werner, JA Lansky, AJ Wilensky, RL
Citation: Kg. Lehmann et al., Vascular remodeling and the local delivery of cytochalasin B after coronary angioplasty in humans, J AM COL C, 35(3), 2000, pp. 583-591
Prospective study correlating fibrinopeptide A, troponin I, myoglobin, andmyosin light chain levels with early and late ischemic events in consecutive patients presenting to the emergency department with chest pain
Authors: Sonel, A Sasseen, BM Fineberg, N Bang, N Wilensky, RL
Citation: A. Sonel et al., Prospective study correlating fibrinopeptide A, troponin I, myoglobin, andmyosin light chain levels with early and late ischemic events in consecutive patients presenting to the emergency department with chest pain, CIRCULATION, 102(10), 2000, pp. 1107-1113
Predictors of clinical outcome following percutaneous intervention for in-stent restenosis
Authors: Klugherz, BD Meneveau, NF Kolansky, DM Herrmann, HC Schiele, F Matthai, WH Groh, WC Untereker, WJ Hirshfeld, JW Bassand, JPL Wilensky, RL
Citation: Bd. Klugherz et al., Predictors of clinical outcome following percutaneous intervention for in-stent restenosis, AM J CARD, 85(12), 2000, pp. 1427-1431
Heparin infusion prior to stenting (HIPS) trial: Final results of a prospective, randomized, controlled trial evaluating the effects of local vascular delivery on intimal hyperplasia
Authors: Wilensky, RL Tanguay, JF Ito, S Bartorelli, AL Moses, J Williams, DO Bailey, SR Martin, J Bucher, TA Gallant, P Greenberg, A Popma, JJ Weissman, NJ Mintz, GS Kaplan, AV Leon, MB
Citation: Rl. Wilensky et al., Heparin infusion prior to stenting (HIPS) trial: Final results of a prospective, randomized, controlled trial evaluating the effects of local vascular delivery on intimal hyperplasia, AM HEART J, 139(6), 2000, pp. 1061-1070
Increased thrombin activity correlates with increased ischemic event rate after percutaneous transluminal coronary angioplasty: Lack of efficacy of locally delivered urokinase
Authors: Wilensky, RL Pyles, JM Fineberg, N
Citation: Rl. Wilensky et al., Increased thrombin activity correlates with increased ischemic event rate after percutaneous transluminal coronary angioplasty: Lack of efficacy of locally delivered urokinase, AM HEART J, 138(2), 1999, pp. 319-325
Risultati: 1-8 |